Slow Capital Inc. Raises Position in GRAIL, Inc. $GRAL

Slow Capital Inc. increased its stake in GRAIL, Inc. (NASDAQ:GRAL) by 5.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 142,840 shares of the company’s stock after buying an additional 6,883 shares during the quarter. GRAIL comprises 0.9% of Slow Capital Inc.’s portfolio, making the stock its 29th largest position. Slow Capital Inc.’s holdings in GRAIL were worth $7,345,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in GRAIL in the fourth quarter valued at approximately $1,201,000. California State Teachers Retirement System purchased a new position in shares of GRAIL in the fourth quarter valued at $464,000. GAMMA Investing LLC grew its holdings in GRAIL by 4,102.5% during the 1st quarter. GAMMA Investing LLC now owns 25,131 shares of the company’s stock valued at $642,000 after purchasing an additional 24,533 shares in the last quarter. Merit Financial Group LLC purchased a new stake in GRAIL during the 1st quarter worth $206,000. Finally, Wesbanco Bank Inc. lifted its holdings in GRAIL by 9.2% in the 1st quarter. Wesbanco Bank Inc. now owns 32,000 shares of the company’s stock worth $817,000 after buying an additional 2,700 shares in the last quarter.

GRAIL Stock Performance

Shares of GRAL stock opened at $61.70 on Tuesday. The stock has a market capitalization of $2.22 billion, a price-to-earnings ratio of -4.71 and a beta of 4.11. GRAIL, Inc. has a one year low of $12.33 and a one year high of $73.74. The company’s 50-day simple moving average is $39.16 and its 200-day simple moving average is $37.47.

GRAIL (NASDAQ:GRAL) last announced its quarterly earnings data on Tuesday, August 12th. The company reported ($3.18) earnings per share for the quarter, missing the consensus estimate of ($3.14) by ($0.04). GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. The firm had revenue of $35.54 million during the quarter, compared to the consensus estimate of $37.57 million. As a group, research analysts forecast that GRAIL, Inc. will post -15.15 EPS for the current year.

Insider Buying and Selling

In other GRAIL news, CFO Aaron Freidin sold 8,000 shares of GRAIL stock in a transaction on Tuesday, July 15th. The shares were sold at an average price of $38.93, for a total value of $311,440.00. Following the completion of the transaction, the chief financial officer owned 286,020 shares of the company’s stock, valued at $11,134,758.60. The trade was a 2.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, President Joshua J. Ofman sold 9,692 shares of the business’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $64.00, for a total transaction of $620,288.00. Following the sale, the president owned 478,182 shares of the company’s stock, valued at approximately $30,603,648. The trade was a 1.99% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 21,894 shares of company stock valued at $1,066,276 over the last quarter.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on GRAL. Weiss Ratings restated a “sell (d-)” rating on shares of GRAIL in a research note on Saturday, September 27th. UBS Group set a $75.00 price objective on GRAIL in a research note on Friday. Finally, Canaccord Genuity Group lifted their price objective on GRAIL from $43.00 to $75.00 and gave the stock a “buy” rating in a report on Friday. One equities research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, GRAIL presently has a consensus rating of “Hold” and an average price target of $56.67.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.